Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSecure Trust Bank Regulatory News (STB)

Share Price Information for Secure Trust Bank (STB)

Share Price is delayed by 15 minutes
Get Live Data
1,254.00    -22.00 (-1.72%)
Bid:
1,258.00
Ask:
1,280.00
Spread: 22.00 (1.749%)
Market Cap: £234.93m
STB Live PriceLast checked at - London Stock Exchange

Intraday Secure Trust Bank Share Chart

Placing Agreement

19 Jun 2014 18:26

RNS Number : 0977K
Secure Trust Bank PLC
19 June 2014
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

 

 

19 June 2014

 

Secure Trust Bank PLC (the "Company")

Following the Company's announcement earlier today, the Company has now entered into the Placing Agreement.

This announcement should be read together with the announcement made by the Company at 6:10 p.m. on 19 June 2014 and all terms in this announcement have the meaning given to them in that announcement unless otherwise defined in this announcement.

Enquiries:

Secure Trust Bank PLC 0121 693 9100

Paul Lynam

Neeraj Kapur

Oriel Securities Limited (Joint Broker, Placing Agent and Joint Bookrunner) 0207 710 7600

Robin Mann

Gareth Hunt

Stewart Wallace

Keefe, Bruyette & Woods Limited (Joint Bookrunner) 0207 663 3161

Charles Lucas

Canaccord Genuity Limited (NOMAD and Joint Broker) 0207 523 8000 / 0207 665 4500

Lawrence Guthrie

Sunil Duggal

Bell Pottinger

Ben Woodford

Dan de Belder

 

IMPORTANT NOTICES

This Announcement has been issued by, and is the sole responsibility of, the Company.

This Announcement provides information about the Placing, but does not invite participation in the Placing. This Announcement does not constitute, and the Company is not making, an offer to the public of transferable securities within the meaning of sections 85 and 102B of the Financial Services and Markets Act 2000 ("FSMA"). This Announcement is therefore not an approved prospectus for the purposes of section 85 of FSMA, and has not been prepared in accordance with the prospectus rules of the Financial Conduct Authority ("FCA") and as such neither its contents nor its issue have been approved by the FCA or by any authority which would be a competent authority for the purposes of any legislation that implements the Prospectus Directive.

This Announcement and the information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Japan, the Republic of South Africa or any other state or jurisdiction into which the same would be unlawful. This Announcement is for information purposes only and shall not constitute an offer to buy, sell, issue, or acquire, or the solicitation of an offer to buy, sell, issue, or acquire any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

This Announcement does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which such offer, solicitation or sale would be unlawful. In particular, the Placing Shares and the Sale Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered, sold or transferred, directly or indirectly, within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and the securities laws of any state or other jurisdiction of the United States. No public offering of the Placing Shares or the Sale Shares is being made in the United States, Australia, Canada, Japan or the Republic of South Africa.

Oriel Securities Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as joint broker, placing agent and joint bookrunner to the Company in connection with the Placing and is acting exclusively for the Company and for no one else (other than Arbuthnot) in relation to the Placing and will not be responsible to any person other than the Company and Arbuthnot for providing the protections afforded to its clients or for advising any other person in relation to the Placing, Admission or any matter referred to in this Announcement.

Keefe, Bruyette & Woods Limited, which is authorised and regulated in the United Kingdom by the FCA, is acting as joint bookrunner to the Company in connection with the Placing and is acting exclusively for the Company and for no one else (other than Arbuthnot) in relation to the Placing and will not be responsible to any person other than the Company and Arbuthnot for providing the protections afforded to its clients or for advising any other person in relation to the Placing, Admission or any matter referred to in this Announcement.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the FCA, is the Company's Nominated Adviser. The responsibilities of Canaccord Genuity Limited, as Nominated Adviser under the AIM Rules and the AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange and are not owed to the Company, any Shareholder or any Director of the Company or to any other person in respect of his or her decision to acquire Placing Shares or Sale Shares. Canaccord Genuity Limited is acting exclusively for the Company and for no one else (other than Arbuthnot) in relation to the Placing and Admission and will not be responsible to any person other than the Company and Arbuthnot for providing the protections afforded to its clients or for providing advice in relation to the Placing, Admission or otherwise.

The price of shares and the income from them may go down as well as up and investors may not get back the full amount invested on disposal of the shares. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser.

No representation or warranty, express or implied, is or will be made by or on behalf of any of Canaccord Genuity Limited, Oriel Securities Limited or Keefe, Bruyette & Woods Limited and no responsibility or liability is or will be accepted by any of Canaccord Genuity Limited, Oriel Securities Limited or Keefe, Bruyette & Woods Limited or any of their respective affiliates, as to the accuracy, completeness or verification of the information set out in this Announcement, and nothing contained in this Announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or the future. Canaccord Genuity Limited, Oriel Securities Limited and Keefe, Bruyette & Woods Limited and each of their respective affiliates accordingly disclaim, to the fullest extent permitted by law, all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this Announcement or any such statement.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this Announcement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFDRVIALIS
Date   Source Headline
17th Aug 20232:10 pmRNSDirector/PDMR Shareholding
10th Aug 202310:54 amRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20232:25 pmRNSHolding(s) in Company
1st Aug 20235:23 pmRNSTotal Voting Rights
14th Jul 20232:33 pmRNSIssue of Equity
3rd Jul 20232:04 pmRNSBlock listing Interim Review
3rd Jul 20232:02 pmRNSTotal Voting Rights
3rd Jul 20231:59 pmRNSChange of Registered Office
23rd Jun 20235:00 pmRNSIssue of Equity
16th Jun 202311:39 amRNSDirector/PDMR Shareholding
1st Jun 202311:20 amRNSTotal Voting Rights
18th May 20234:34 pmRNSResult of AGM
18th May 20237:00 amRNSQ1 2023 Trading Update
17th May 20235:29 pmRNSIssue of Equity
3rd May 20233:26 pmRNSTotal Voting Rights
27th Apr 20231:50 pmRNSIssue of Equity
13th Apr 20234:13 pmRNSIssue of Equity
11th Apr 20234:46 pmRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20233:19 pmRNSTotal Voting Rights
31st Mar 20232:00 pmRNSDirector/PDMR Shareholding
31st Mar 20232:00 pmRNSDirector/PDMR Shareholding
30th Mar 20237:01 amRNSChairman to retire AGM 2024
30th Mar 20237:00 amRNSSecure Trust Bank Annual Results to End of 2022
17th Mar 20235:03 pmRNSTotal Voting Rights
17th Mar 20231:58 pmRNSBuyback of Tier 2 Bonds
14th Mar 20233:37 pmRNSIssue of Equity
9th Mar 20234:34 pmRNSHolding(s) in Company
1st Mar 20232:23 pmRNSTotal Voting Rights
27th Feb 202310:28 amRNSPublication of Admission Particulars
22nd Feb 20236:20 pmRNSNew Tier 2 Issue Pricing and Buyback of securities
16th Feb 20233:26 pmRNSIssue of Equity
9th Feb 20234:54 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSIssue of Equity
19th Jan 20237:00 amRNSPre Close Trading Update
9th Jan 20234:39 pmRNSBlock listing Interim Review
4th Jan 20234:35 pmRNSPrice Monitoring Extension
4th Jan 202311:22 amRNSAdditional Listing
3rd Jan 202311:30 amRNSTotal Voting Rights
1st Dec 202212:13 pmRNSTotal Voting Rights
15th Nov 202210:42 amRNSIssue of Equity
9th Nov 20224:28 pmRNSIssue of Equity
9th Nov 20223:53 pmRNSPurchase of shares by Employee Benefit Trust
28th Oct 20222:50 pmRNSChange of Directors' Details
27th Oct 20227:00 amRNSQ3 2022 Trading Update
21st Sep 20225:35 pmRNSDirector/PDMR Shareholding
21st Sep 20227:00 amRNSDirectorate Change
15th Sep 20229:57 amRNSHolding(s) in Company
8th Sep 20224:04 pmRNSHolding(s) in Company
5th Sep 20221:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.